Michael Wilcock (Mark Horowitz, Mike Wilcock)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Prognostic Factors

Oral Anticoagulants

Atopic Dermatitis

Top Venues

Drug and therapeutics bulletin

The International journal of pharmacy practice

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Wilcock
Limiting drugs prescribed in primary care. Drug and therapeutics bulletin 62 (2) (2024)
Michael Wilcock
Limiting drugs prescribed in primary care. Drug and therapeutics bulletin 62 (2) (2024)
Michael Wilcock, Liam Bastian, Anne Jones, Wasim Baqir
Community pharmacy discharge medicines service activity as recorded in PharmOutcomes: a retrospective exploration and analysis. The International journal of pharmacy practice (2024)
Michael Wilcock, Liam Bastian, Anne Jones, Wasim Baqir
Community pharmacy discharge medicines service activity as recorded in PharmOutcomes: a retrospective exploration and analysis. The International journal of pharmacy practice 32 (4) (2024)
Michael Wilcock
Limiting drugs prescribed in primary care. Drug and therapeutics bulletin (2024)
Michael Wilcock
Medicines optimisation opportunities: driving change? Drug and therapeutics bulletin (2024)
Michael Wilcock, Daniel Hearsey
Delabelling penicillin allergy revisited. Drug and therapeutics bulletin 61 (3) (2023)
David Branford, Michael Wilcock
STOMP and STAMP campaigns: success or failure? Drug and therapeutics bulletin 60 (8) (2022)
Michael Wilcock, Michael Wilcock
Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stop. Drug and therapeutics bulletin 60 (1) (2021)
Michael Wilcock, David Bearman
Community pharmacy discharge medicines service: a step towards improved patient safety? Drug and therapeutics bulletin 59 (8) (2021)
Michael Wilcock, Alastair D Hay
Can we achieve shorter antibiotic courses in primary care? Drug and therapeutics bulletin 59 (9) (2021)
Michael Wilcock, Neil Powell
Challenges of delabelling penicillin allergy. Drug and therapeutics bulletin 59 (11) (2021)
Michael Wilcock
Pharmaceutical marketing-greater than the sum of its parts? Drug and therapeutics bulletin 58 (10) (2020)
Michael Wilcock, Andrew Sibley, Richard Blackwell, Bettina Kluettgens, Sarah Robens, Liam Bastian
Involving community pharmacists in transfer of care from hospital: Indications of reduced 30-day hospital readmission rates for patients in Cornwall. The International journal of pharmacy practice 28 (4) (2020)
Michael Wilcock, Anurita Rohilla
Three decades of shared care guidelines: are we any further forward? Drug and therapeutics bulletin 58 (5) (2020)
Barry Jubraj, Stephen Morris, Michael Wilcock
How do your patients use their medicines at home and why is it important to know? Drug and therapeutics bulletin 59 (1) (2020)
Michael Wilcock
Dilemmas in commissioning biological therapies. Drug and therapeutics bulletin 58 (9) (2020)
Michael Wilcock, Neil Powell
Can patients in hospital become guardians of antimicrobial stewardship? Drug and therapeutics bulletin 57 (8) (2019)
Michael Wilcock, Alison Hill, Amber Wynn, Liam Kelly
Accuracy of pharmacist electronic discharge medicines review information transmitted to primary care at discharge. International journal of clinical pharmacy 41 (3) (2019)
Michael Wilcock, David Bearman
Community pharmacist management of discharge medication summaries in primary care. Drug and therapeutics bulletin 57 (12) (2019)
Michael Wilcock
It is hard work being a patient. Drug and therapeutics bulletin 57 (7) (2019)